Celaid Therapeutics will be exhibiting at booth R-54 at the “Regenerative Medicine Japan” event to be held at Pacifico Yokohama from October 9th to October 11th, 2024.
Also, from 10:00 to 11:00 on October 10, our company's Asako Uchiyama (Director, Chief Development Officer) is scheduled to appear at the pitch event to be held at the JHVS Venture Awards 2024 in the venue.
Regenerative Medicine Japan and the concurrent Bio Japan event are the largest partnering events in Asia for the bio business. We look forward to welcoming everyone involved in the bio business!
